Mathematical modeling of erythropoietin therapy in uremic anemia. Does it improve cost-effectiveness?

R. Bellazzi, C. Siviero, R. Bellazzi

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

This paper describes the improvements in r-HuEPO therapy of uremic patients that may be obtained by using a mathematical model of patient response together with a delivery control strategy derived from the theory of industrial control. A mathematical model of r-HuEPO action is presented, and its applicability to dialytic patients is shown. Moreover, a new statistical technique for identifying the parameters of the mathematical model analyzing a patient population is summarized, and a control strategy for r-HuEPO delivery in uremic patients based on a Fuzzy Set Controller is introduced. Some results obtained from simulation, are presented.

Original languageEnglish
Pages (from-to)154-164
Number of pages11
JournalHaematologica
Volume79
Issue number2
Publication statusPublished - 1994

Fingerprint

Erythropoietin
Cost-Benefit Analysis
Anemia
Theoretical Models
Therapeutics
Population

Keywords

  • cost-effectiveness
  • erythropoietin therapy
  • mathematical modeling
  • uremic anemia

ASJC Scopus subject areas

  • Hematology

Cite this

Mathematical modeling of erythropoietin therapy in uremic anemia. Does it improve cost-effectiveness? / Bellazzi, R.; Siviero, C.; Bellazzi, R.

In: Haematologica, Vol. 79, No. 2, 1994, p. 154-164.

Research output: Contribution to journalArticle

@article{92613064e30949f5b41431f98396ba4d,
title = "Mathematical modeling of erythropoietin therapy in uremic anemia. Does it improve cost-effectiveness?",
abstract = "This paper describes the improvements in r-HuEPO therapy of uremic patients that may be obtained by using a mathematical model of patient response together with a delivery control strategy derived from the theory of industrial control. A mathematical model of r-HuEPO action is presented, and its applicability to dialytic patients is shown. Moreover, a new statistical technique for identifying the parameters of the mathematical model analyzing a patient population is summarized, and a control strategy for r-HuEPO delivery in uremic patients based on a Fuzzy Set Controller is introduced. Some results obtained from simulation, are presented.",
keywords = "cost-effectiveness, erythropoietin therapy, mathematical modeling, uremic anemia",
author = "R. Bellazzi and C. Siviero and R. Bellazzi",
year = "1994",
language = "English",
volume = "79",
pages = "154--164",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "2",

}

TY - JOUR

T1 - Mathematical modeling of erythropoietin therapy in uremic anemia. Does it improve cost-effectiveness?

AU - Bellazzi, R.

AU - Siviero, C.

AU - Bellazzi, R.

PY - 1994

Y1 - 1994

N2 - This paper describes the improvements in r-HuEPO therapy of uremic patients that may be obtained by using a mathematical model of patient response together with a delivery control strategy derived from the theory of industrial control. A mathematical model of r-HuEPO action is presented, and its applicability to dialytic patients is shown. Moreover, a new statistical technique for identifying the parameters of the mathematical model analyzing a patient population is summarized, and a control strategy for r-HuEPO delivery in uremic patients based on a Fuzzy Set Controller is introduced. Some results obtained from simulation, are presented.

AB - This paper describes the improvements in r-HuEPO therapy of uremic patients that may be obtained by using a mathematical model of patient response together with a delivery control strategy derived from the theory of industrial control. A mathematical model of r-HuEPO action is presented, and its applicability to dialytic patients is shown. Moreover, a new statistical technique for identifying the parameters of the mathematical model analyzing a patient population is summarized, and a control strategy for r-HuEPO delivery in uremic patients based on a Fuzzy Set Controller is introduced. Some results obtained from simulation, are presented.

KW - cost-effectiveness

KW - erythropoietin therapy

KW - mathematical modeling

KW - uremic anemia

UR - http://www.scopus.com/inward/record.url?scp=0028232996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028232996&partnerID=8YFLogxK

M3 - Article

C2 - 8063263

AN - SCOPUS:0028232996

VL - 79

SP - 154

EP - 164

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 2

ER -